Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumour. Due to a high tumour recurrence rate, the post-operative overall survival (OS) and disease-free survival (DFS) of ACCs is limited. Our research aims to identify the role of the epithelial-mesenchymal transition (EMT) re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Liang, Jiayu, Liu, Zhihong, Wei, Xin, Zhou, Liang, Tang, Yongquan, Zhou, Chuan, Wu, Kan, Zhang, Fuxun, Zhang, Fan, Lu, Yiping, Zhu, Yuchun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884893/
https://ncbi.nlm.nih.gov/pubmed/31783819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6389-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller